摘要
目的 研究分析纤溶酶注射液联合高压氧治疗缺血性脑卒中的临床价值。方法 选择我院2021年4月至2023年3月期间收治的缺血性脑卒中患者60例，随机数字表法分为研究组、对照组，各30例。两组患者开展缺血性脑卒中常规治疗，对照组给予纤溶酶注射液治疗，研究组联合开展高压氧治疗，就两组患者治疗效果、神经功能与日常生活活动能力、肢体功能改善情况等进行评价对比。结果 治疗后研究组患者治疗总有效率高于对照组，NIHSS量表评分低于对照组，BI评分高于对照组，FMA评分低于对照组，差异均有统计学意义（P＜0.05）。结论 对缺血性脑卒中患者开展纤溶酶注射液联合高压氧治疗，可以提升疗效，促进患者神经功能与日常生活活动能力的恢复，同时改善肢体功能。
关键词： 缺血性脑卒中；纤溶酶注射液；高压氧；神经功能；日常生活活动能力
Abstract
Objective To study and analyze the clinical value of plasminase injection combined with hyperbaric oxygen in the treatment of ischemic stroke. Methods A total of 60 patients with ischemic stroke admitted to our hospital from April 2021 to March 2023 were selected and divided into study group and control group with 30 patients in each group by random number table method. The patients in the two groups received routine treatment for ischemic stroke, the control group received plasminase injection treatment, and the research group jointly received hyperbaric oxygen therapy. The therapeutic effect, neurological function, activity of daily living, and improvement of limb function of the two groups were evaluated and compared. Results After treatment, the total effective rate of the study group was higher than that of the control group, the score of NIHSS scale was lower than that of the control group, the score of BI was higher than that of the control group, and the score of FMA was lower than that of the control group, with statistical significance (P < 0.05). Conclusion Plasminase injection combined with hyperbaric oxygen therapy for patients with ischemic stroke can improve the therapeutic effect, promote the recovery of nerve function and daily living ability of patients, and improve limb function.
Key words： Ischemic stroke; Plasminase injection; Hyperbaric oxygen; Nerve function; Ability to perform activities in daily living
参考文献 References
[1] 许海东,张丽丽,王敏.血浆D-二聚体、中性粒细胞/淋巴细胞及血小板/淋巴细胞在老年急性缺血性脑卒中患者预后中的临床价值[J].中国老年学杂志,2024,44(10): 2324-2327.
[2] Cui X Y ,Song J C ,Hou S X , et al. Vertebral Artery Stenting for Acute Multiple Cerebral Infarctions Caused by Vertebral Artery Dissection After Massage: A Case Report.[J]. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,2024.
[3] 王震,冯慧,周修五,等.超早期滋养性肠内营养联合高压氧治疗急性缺血性脑卒中的临床疗效[J].川北医学院学报,2024,39(01):104-107.
[4] 李攀攀,彭莹娟,祁萌,等.高压氧联合阿替普酶治疗急性缺血性脑卒中的效果及对血清PARK7、Sestrin2水平的影响[J].中国老年学杂志,2022,42(21):5168-5171.
[5] 高晓玲,田齐,高继英,等.血清IMA、NFL、Occludin在急性缺血性脑卒中诊断及高压氧疗效预测中的应用价值研究[J].解放军医药杂志,2022,34(10):16-21.
[6] 杨保华,付胜,伏冬梅.舒血宁注射液联合重组组织型纤溶酶原激活剂静脉溶栓治疗急性缺血性脑卒中疗效及对血清脂蛋白相关磷脂酶A2、同型半胱氨酸、高敏C反应蛋白水平的影响[J].实用医院临床杂志,2020,17(06): 79-82.
[7] 田艳华,张然,李军涛.舒血宁注射液联合重组组织型纤溶酶原激活剂静脉溶栓对急性缺血性脑卒中的疗效[J].河南医学研究,2020,29(15):2811-2813.
[8] 王志国.丹参川芎嗪注射液联合重组组织型纤溶酶原激活剂静脉溶栓对急性缺血性脑卒中患者血液流变学的影响[J].首都食品与医药,2019,26(16):74.
[9] 褚全红.银杏酮酯分散片与纤溶酶注射液联合高压氧治疗急性缺血性脑卒中患者前瞻性研究[J].当代医学,2018, 24(19):20-23.
[10] 吴晓伟,何泉金,康涛生,等.高压氧联合低剂量阿替普酶静脉溶栓治疗老年急性缺血性脑卒中的疗效及对患者神经认知功能、凝血指标的影响[J].现代生物医学进展,2023,23(19):3646-3650.
[11] 陈凯歌,杜迎春,高彦伦.高压氧联合银杏二萜内酯对中青年急性缺血性脑卒中患者脑血流及ESM-1、LP-PLA2、PTX-3水平的影响[J].中医药临床杂志,2023,35(01):139-142.